GPT and End Stage Liver Disease: Recent studies have showed that non-invasive scores, such as the model for end-stage liver disease (MELD), aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AST/ALT), AST to platelet ratio index (APRI), fibrosis-4-index (FIB-4), fibrosis index (FI), and King’s score, are simple, non-invasive methods which could be used in the prediction of EV in cirrhotic patients [9,10,11,12,13,14,15,16].